Litcius/Paper detail

Cardiovascular Benefits of GLP-1 Receptor Agonists in Patients Living with Obesity or Overweight: A Meta-analysis of Randomized Controlled Trials

Gustavo de Oliveira Almeida, Thiago Nienkötter, Caroline Cristine Almeida Balieiro, Eric Pasqualotto, Júlia Braga Cintra, Henrique Champs Porfírio Carvalho, Ana Laura Soares Silva, Júlia Camargo Kabariti, Bárbara Silvestre Minucci, Edmundo Damiani Bertoli, Camila Mota Guida

2024American Journal of Cardiovascular Drugs36 citationsDOI

Topics & Concepts

MedicineOverweightInternal medicineBlood pressurePlaceboRandomized controlled trialRelative riskObesityMyocardial infarctionCardiologyConfidence intervalGastroenterologyAlternative medicinePathologyDiabetes Treatment and ManagementBariatric Surgery and OutcomesPharmacology and Obesity Treatment
Cardiovascular Benefits of GLP-1 Receptor Agonists in Patients Living with Obesity or Overweight: A Meta-analysis of Randomized Controlled Trials | Litcius